✦ LIBER ✦

Insulin glargine in combination with oral antidiabetic drugs as a cost-equivalent alternative to conventional insulin therapy in type 2 diabetes mellitus

✍ Scribed by Monika Lechleitner; Michael Roden; Eva Haehling; Markus Mueller

Publisher: Springer Vienna
Year: 2005
Tongue: English
Weight: 94 KB
Volume: 117
Category: Article
ISSN: 0043-5325
DOI: 10.1007/s00508-005-0429-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised, 52-week, treat-to-target t

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

✍ J. Rosenstock; M. Davies; P. D. Home; J. Larsen; C. Koenen; G. Schernthaner 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 179 KB

Liraglutide vs insulin glargine and plac

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

✍ D. Russell-Jones; A. Vaag; O. Schmitz; B. K. Sethi; N. Lalic; S. Antic; M. Zdrav 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 193 KB

Therapy conversion to insulin detemir am

Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: A modeling study of cost-effectiveness in the United States

✍ William J. Valentine; K. M. Erny-Albrecht; J. A. Ray; S. Roze; D. Cobden; A. J. 📂 Article 📅 2007 🏛 Springer Healthcare Communications 🌐 English ⚖ 225 KB